Navigation Links
Challenges remain in reintroducing American chestnut
Date:9/5/2007

WEST LAFAYETTE, Ind. - Researchers have developed a breed of American chestnut that is resistant to the fungal blight that decimated its population in the early 1900s.

But the return of this "king of trees," so-called for its picturesque form and towering height of more than 100 feet, remains hampered by a slew of obstacles, said a Purdue University researcher.

"We are on the verge of overcoming chestnut blight, but there is a whole new set of obstacles to get past yet," said Douglass Jacobs, an associate professor of forestry and natural resources who is helping develop the blight-resistant chestnut.

To reintroduce the American chestnut, he said, researchers must get past several policy limitations, gather new data, educate the public about the species and address new threats posed by exotic pests. He details these and other challenges in a paper published in July's issue of the journal Biological Conservation.

Once a dominant forest species throughout much of the Eastern United States, ranging from Maine to Mississippi and concentrated in the Appalachian regions, the American chestnut was known for its annual largesse of nuts, rot-resistant wood and sheer size. An introduced Asian fungus nearly eliminated the tree.

A breeding program begun by the American Chestnut Foundation recently produced a blight-resistant hybrid tree that derives its resistance from the Asian chestnut and contains 94 percent of the American chestnut's genetic material, Jacobs said.

Nevertheless, the supply of blight-resistant trees remains low, and the tree isn't likely to be available to the public for about a decade. More resources need to be directed toward breeding programs, he said.

More existing trees also need to be included in breeding programs as soon as possible to produce a genetically diverse population, Jacobs said. Although few adult chestnuts remain throughout the tree's native territory, a significant num
'/>"/>

Contact: Douglas M. Main
dmain@purdue.edu
765-496-2050
Purdue University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Changing ecosystems throw scientists mega-challenges
2. Measurement Challenges In Detecting Cancer Biomarkers
3. Grand Challenges in Global Health initiative funds Yale project
4. Report focuses on challenges to unlocking future promise of vaccines
5. The brain, traffic and nano-circuits -- e-Science takes on major challenges
6. Study challenges myth that sex late in pregnancy hastens birth
7. AIDS study challenges conventional treatment guidelines for HIV patients
8. Chinas environmental challenges
9. New study challenges critical period in childhood vision development
10. Paper challenges 1491 Amazonian population theories
11. The quest for an effective HIV vaccine presents new possibilities, challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... , Jan. 28, 2015 Research and Markets ... addition of the "Global Biometrics Market (2014-2020): ... and Countries " report to their offering. ... Asia-Pacific is anticipated to overtake ... owing to increasing government spending towards IT security, ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... the only ones making exciting scientific discoveries these days. ... of scientists who are reporting the first glimpse of ... helps activate certain antibiotics and anti-cancer agents so that ... ACS, weekly journal Biochemistry . The student co-authors ...
... College Park, MD (July 27, 2010) -- Kites have a ... and his study of electricity -- including being used to ... sensors, because they were exposed to direct sunlight, were prone ... the University of Reading in the United Kingdom have developed ...
... MN Current research suggests that taking morphine can ... related report by Koodie et al, "Morphine suppresses tumor ... 2010 issue of the American Journal of Pathology ... analgesics used to relieve severe pain and suffering. ...
Cached Biology News:
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
(Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
(Date:2/26/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... and commercializes proprietary technologies and products for advanced microarray ... the fiscal first quarter ended December  31, 2014. All ... (CAD), unless otherwise stated. "During the ... our existing customers and add to our sales pipeline," ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Calif., Feb. 27 Telik, Inc.,(Nasdaq: TELK ) ... per share,for the fourth quarter ended December 31, 2007, ... per share, for the comparable period in 2006., ... costs and,expenses were $13.5 million, compared with $19.5 million ...
... ZARS Pharma, Inc. announced,today that Rapydan(R) ... now received marketing authorization in Sweden, the ... Czech Republic, Greece, Ireland,Norway and Portugal following ... ZARS Pharma has licensed the European sales ...
... Fla., Feb. 27 Imaging,Diagnostic Systems, Inc., ... laser,optical breast imaging systems, will exhibit CT ... National Interdisciplinary Breast Cancer,Conference, March 1-5, in ... at booth,#43., (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ...
Cached Biology Technology:Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 2Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 3Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 4ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe 2ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe 3CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference 2
...
The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or ...
MOUSE ANTI HUMAN MOC31:AZIDE FREE...
... The mycobacteria in ... cells to the injection site which enhances ... Freund's Adjuvant is used for the initial ... the subsequent boosts. Antigens (preferably in saline) ...
Biology Products: